Show simple item record

dc.contributor.authorAhmadvand, Alireza
dc.contributor.authorDrennan, Judy
dc.contributor.authorBurgess, Jean
dc.contributor.authorClark, Michele
dc.contributor.authorKavanagh, David
dc.contributor.authorBurns, Kara
dc.contributor.authorHoward, Sarah
dc.contributor.authorKelly, Fleur
dc.contributor.authorCampbell, Chris
dc.contributor.authorNissen, Lisa
dc.date.accessioned2020-06-22T02:53:11Z
dc.date.available2020-06-22T02:53:11Z
dc.date.issued2018
dc.identifier.issn2044-6055
dc.identifier.doi10.1136/bmjopen-2017-019422
dc.identifier.urihttp://hdl.handle.net/10072/394771
dc.description.abstractIntroduction: Low health literacy is common in people with type 2 diabetes mellitus (T2DM) (up to 40%), associated with decreased self-efficacy in managing T2DM and its important complications, mainly hypertension. This study introduces, for the first time, an easy-to-use solution based on augmented reality (AR) on smartphones, to enhance health literacy around antihypertensive medicines. It assesses the feasibility of the solution for improving health literacy, oriented specifically to angiotensin II receptor blockers; embedding the health literacy improvement into the use cycle of angiotensin II receptor blockers and providing continuous access to information as a form of patient engagement. Methods and analysis: This is a technology evaluation study with one technology group (AR plus usual care) and one non-technology group (usual care). Both groups receive face-to-face communications with community pharmacists regarding angiotensin II receptor blockers; the technology group receive additional AR-enhanced digital consumer medicine information throughout the use of their medications. The primary outcome is the change in health literacy and the hypothesis is that the proportions of people who show high health literacy will be larger in the technology group. Mixed effects models will be used to analyse solution effectiveness on outcomes. Multiple regression models will be used to find additional variables that might affect the relationship between health literacy and the AR solution. Ethics and dissemination: Queensland University of Technology (QUT) Human Research Ethics Committee has approved the study as a low-risk technology evaluation study (approval number: 1700000275). Findings will be disseminated via attending scientific conferences and publishing in peer-reviewed journals. Facilitated by QUT, two press releases have been published in public media and two presentations have been made in university classrooms.
dc.description.peerreviewedYes
dc.languageEnglish
dc.language.isoeng
dc.publisherBMJ Publishing Group
dc.relation.ispartofpagefrome019422:1
dc.relation.ispartofpagetoe019422:6
dc.relation.ispartofissue4
dc.relation.ispartofjournalBMJ Open
dc.relation.ispartofvolume8
dc.subject.fieldofresearchClinical sciences
dc.subject.fieldofresearchHealth services and systems
dc.subject.fieldofresearchPublic health
dc.subject.fieldofresearchOther health sciences
dc.subject.fieldofresearchcode3202
dc.subject.fieldofresearchcode4203
dc.subject.fieldofresearchcode4206
dc.subject.fieldofresearchcode4299
dc.subject.keywordshealth informatics
dc.subject.keywordshypertension
dc.subject.keywordsinformation technology
dc.subject.keywordstelemedicine
dc.titleNovel augmented reality solution for improving health literacy around antihypertensives in people living with type 2 diabetes mellitus: Protocol of a technology evaluation study
dc.typeJournal article
dc.type.descriptionC1 - Articles
dcterms.bibliographicCitationAhmadvand, A; Drennan, J; Burgess, J; Clark, M; Kavanagh, D; Burns, K; Howard, S; Kelly, F; Campbell, C; Nissen, L, Novel augmented reality solution for improving health literacy around antihypertensives in people living with type 2 diabetes mellitus: Protocol of a technology evaluation study, BMJ Open, 2018, 8 (4), pp. e019422:1-e019422:6
dcterms.licensehttps://creativecommons.org/licenses/by/4.0/
dc.date.updated2020-06-22T02:28:44Z
dc.description.versionVersion of Record (VoR)
gro.rights.copyright© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/
gro.hasfulltextFull Text
gro.griffith.authorAhmadvand, Alireza
gro.griffith.authorBurns, Kara R.


Files in this item

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record